Abbott reports Q3 Worldwide Medical Devices sales up 11.7% on reported basis

Worldwide Medical Devices sales increased 11.7% on a reported basis and 13.3% on an organic basis in the third quarter, including double-digit organic growth in both the U.S. and internationally. Sales growth was led by double-digit growth in Diabetes Care, Structural Heart, Heart Failure, and Electrophysiology. Several products contributed to the strong performance, including FreeStyle Libre, Navitor, TriClip, Amplatzer Amulet, and AVEIR. In Electrophysiology, sales grew 12.2% on a reported basis and 14.3% on an organic basis, which included double-digit growth in catheters and cardiac mapping-related products. In Diabetes Care, sales of continuous glucose monitors exceeded $1.6B and grew 19.1% on a reported basis and 20.7% on an organic basis.